Health Care & Life Sciences » Pharmaceuticals | JW Pharmaceutical Corp.

JW Pharmaceutical Corp.

JW Pharmaceutical Corp.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW66.42
Market Cap
KRW632.13 B
Shares Outstanding
20.32 M
Public Float
11.28 M
JW Pharmaceutical Corp. Pfd. Series 2
Stock Exchange Korea Exchange Commodity Market
EPS
-
Market Cap
KRW1.05 T
Shares Outstanding
86.1 K
Public Float
-
JW Pharmaceutical Corp. Pfd. Series 1
Stock Exchange Korea Exchange Commodity Market
EPS
KRW66.42
Market Cap
KRW524.77 B
Shares Outstanding
167.38 K
Public Float
160 K

Profile

Address
JW Tower
Seoul SL 06725
Korea, Republic Of
Employees -
Website http://www.jw-pharma.co.kr
Updated 07/08/2019
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. Its products include analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, antifungal agents, circulatory system agents, gastrointestinal agents, miscellaneous, multivitamins and anti-anemic agents, contact lens care and ophthalmic agents, topicals, amino acid solutions, flexible intravenous container, intravenous solutions, respiratory agents, obstetrics and gynecology agents, nephrology agents, central nervous system, urology agents, and diabetic agents. The company was founded on August 8, 1945 and is headquartered in Seoul, South Korea.

Financials

View All
Created with Highcharts 5.0.14JW Pharmaceutical Corp.Net Income. Fiscal year is January-December. All values KRW Millions.2 2752 2751 4471 4472 1362 13610 93410 9347427428 0578 05720132014201520162017201802.5k5k7.5k10k12.5k
Created with Highcharts 5.0.14JW Pharmaceutical Corp.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.394 182394 182412 791412 791434 352434 352467 465467 465502 919502 919537 182537 1822013201420152016201720180100k200k300k400k500k600k

Kyung-Ha Lee
Chairman
Yeong-Seob Shin
Co-CEO, Director & Head-Pharmaceutical Business